Health Care Supplies

CAINA

CAINA released FY2025 Q4 earnings on April 28 After-Market (BJT), actual revenue CNY 110.92 M, actual EPS CNY -0.0273

CAINA released FY2026 Q1 earnings on April 28 After-Market (BJT), actual revenue CNY 141.35 M, actual EPS CNY 0.11

CAINA released FY2025 Annual Earnings on April 28 After-Market BJT, actual revenue CNY 356.69 M (forecast CNY 360.67 M), actual EPS CNY 0.05 (forecast CNY 0.18)

CAINA FY2026 Q1 Earnings Release Scheduled for April 29 After-Market BJT

CAINA to release FY2025 earnings on April 29 After-Market BJT, forecast revenue CNY 360.67 M, EPS CNY 0.18

CAINA released FY2025 9 Months Earnings on October 24 After-Market (BJT), actual revenue CNY 245.77 M, actual EPS CNY 0.0665

CAINA released FY2025 Q3 earnings on October 24 After-Market BJT, actual revenue CNY 87.39 M, actual EPS CNY -0.0093

CAINA to Release FY2025 Q3 Earnings on October 25 After-Market (BJT)

CAINA released FY2025 Q2 earnings on August 27 After-Market (BJT), actual revenue CNY 85.67 M, actual EPS CNY 0.0159

CAINA released FY2025 Semi-Annual earnings on August 27 After-Market (BJT), actual revenue CNY 158.38 M, actual EPS CNY 0.08

CAINA to Release FY2025 Semi-Annual Earnings on August 28, 2025 (BJT)

Adopt Shares ESG Rating Results Released

Adopt Holdings Subsidiary Obtains Utility Patent for Injection Needle

China Life & CITIC Plan to Reduce Holdings in Adoption Holdings

CAINA released FY2024 Q4 earnings on April 24 After-Market BJT, actual revenue CNY 95.78 M, actual EPS CNY -0.0342

CAINA released FY2025 Q1 earnings on April 24 After-Market BJT, actual revenue CNY 72.71 M, actual EPS CNY 0.06

CAINA released FY2024 annual earnings on April 24 After-Market (BJT), actual revenue CNY 387.89 M (forecast CNY 361.37 M), actual EPS CNY 0.43 (forecast CNY 0.56)

CAINA to Release FY2025 Q1 Earnings on April 25 After-Market BJT

CAINA to release FY2024 earnings on April 25, after-market (BJT), forecast revenue CNY 361.37 M, EPS CNY 0.56

Caina Co., Ltd. Expects a 44.92%-57.36% Decline in Net Profit for 2024

301122

300453

002382

300677

300981

002950

A-share medical consumables stocks continue to rise, ZHYL and INTCO are approaching a 20% limit-up, Allmed Medical and BLUE SAIL MEDICAL previously hit the limit-up, Sanxin Medtec and CAINA have leading gains

Wallstreetcn

Sanxin Medtec

BLUE SAIL MEDICAL

INTCO

ZHYL

Allmed Medical

According to the Zhitong Finance APP, CAINA released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 246 million yuan, a year-on-year decrease of 15.86%. The net profit attributable to shareholders of the listed company was 8.2499 million yuan, a year-on-year decrease of 85.64%. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 1.8827 million yuan. The basic earnings per share were 0.07 yuan

Zhitong

CAINA released its performance for the first three quarters, with a net profit attributable to the parent company of 8.2499 million yuan, a decrease of 85.64%

According to the Zhitong Finance APP, CAINA released its semi-annual report for 2025, showing an operating income of 158 million yuan, a year-on-year decrease of 18.54%. The net profit attributable to shareholders of the listed company was 9.3694 million yuan, a year-on-year decrease of 71.78%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 2.4797 million yuan, a year-on-year decrease of 88.44%. The basic earnings per share were 0.08 yuan

CAINA released its performance for the first half of the year, with a net profit attributable to the parent company of 9.3694 million yuan, a decrease of 71.78%

According to the Qichacha APP, recently, CAINA Jiacheng Technology Co., Ltd. was established, with Yan Qun as the legal representative. The business scope includes: sales of laboratory analytical instruments; sales of special equipment; sales of testing machines; sales of intelligent instruments and meters, etc. Qichacha's equity penetration shows that the company is jointly held by CAINA and others

CAINA and others established a new technology company in Shanghai

According to the Zhitong Finance APP, CAINA disclosed its 2024 annual performance forecast, estimating a net profit attributable to shareholders of the listed company of RMB 48 million to RMB 62 million, a year-on-year decrease of 44.92% to 57.36%; the net profit after deducting non-recurring gains and losses is expected to be RMB 28 million to RMB 40 million, a year-on-year decrease of 52.86% to 67.00%

CAINA issued a profit warning, expecting an annual net profit of 48 million to 62 million yuan, a year-on-year decrease of 44.92% to 57.36%

CAINA announced that it expects the net profit attributable to shareholders of the listed company for the year 2024 to be between 48 million and 62 million yuan, a year-on-year decrease of 44.92% - 57.36%

CAINA: Expected net profit in 2024 to decline by 44.92% - 57.36% year-on-year